Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$18.3M |
| 2 |
WFT
Weatherford International plc
WFT
|
+$16.5M |
| 3 |
ICL Group
ICL
|
+$11.3M |
| 4 |
Liberty Media Series C
FWONK
|
+$9.18M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$6.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$23.7M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$23.5M |
| 3 |
ExxonMobil
XOM
|
+$11.1M |
| 4 |
IBM
IBM
|
+$8.88M |
| 5 |
HSH
HILLSHIRE BRANDS CO
HSH
|
+$8.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.81% |
| 2 | Technology | 13.76% |
| 3 | Energy | 11.48% |
| 4 | Industrials | 10.81% |
| 5 | Consumer Staples | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Northrop Grumman
NOC
$82.1B
| $25.8M | 0.1% |
195,684
-5,000
| -2% | -$631K |
|
227
Allstate
ALL
$68.2B
| $25.8M | 0.1% |
419,873
-15,800
| -4% | -$949K |
|
228
Vertex Pharmaceuticals
VRTX
$133B
| $25.4M | 0.1% |
226,309
-3,500
| -2% | -$333K |
|
229
Devon Energy
DVN
$49.9B
| $25.3M | 0.1% |
371,326
-5,900
| -2% | -$439K |
|
230
Sherwin-Williams
SHW
$88.1B
| $25.2M | 0.1% |
345,483
-7,800
| -2% | -$553K |
|
231
Applied Materials
AMAT
$415B
| $25.2M | 0.1% |
1,165,222
-15,200
| -1% | -$336K |
|
232
DaVita
DVA
$11.7B
| $25M | 0.1% |
341,618
-4,300
| -1% | -$315K |
|
|
PARA
233
DELISTED
Paramount Global Class B
PARA
| $25M | 0.1% |
466,725
-73,600
| -14% | -$4.34M |
|
234
Corning
GLW
$136B
| $24.7M | 0.09% |
1,279,412
-77,500
| -6% | -$1.62M |
|
|
MRO
235
DELISTED
Marathon Oil Corporation
MRO
| $24.6M | 0.09% |
654,397
-24,900
| -4% | -$987K |
|
236
Netflix
NFLX
$318B
| $24.6M | 0.09% |
3,813,250
-63,000
| -2% | -$409K |
|
237
Cardinal Health
CAH
$55.5B
| $24.5M | 0.09% |
326,948
-7,300
| -2% | -$531K |
|
238
American Electric Power
AEP
$66.9B
| $24.4M | 0.09% |
467,789
-7,600
| -2% | -$402K |
|
239
Kroger
KR
$34.6B
| $24.2M | 0.09% |
932,096
-24,400
| -3% | -$617K |
|
240
Perrigo
PRGO
$1.75B
| $24.1M | 0.09% |
160,662
-2,500
| -2% | -$373K |
|
241
Henry Schein
HSIC
$9.82B
| $24M | 0.09% |
524,940
-9,180
| -2% | -$425K |
|
242
Aon
AON
$75.7B
| $23.8M | 0.09% |
271,271
-7,500
| -3% | -$655K |
|
243
Valero Energy
VLO
$90.7B
| $23.7M | 0.09% |
511,148
-7,800
| -2% | -$394K |
|
|
NBL
244
DELISTED
Noble Energy, Inc.
NBL
| $23.6M | 0.09% |
345,544
-5,300
| -2% | -$377K |
|
245
Marathon Petroleum
MPC
$90B
| $23.6M | 0.09% |
557,096
-17,200
| -3% | -$730K |
|
246
Sempra
SRE
$55.1B
| $23.5M | 0.09% |
446,800
-7,000
| -2% | -$361K |
|
247
Cigna
CI
$73.6B
| $23.5M | 0.09% |
258,974
-7,700
| -3% | -$720K |
|
248
Annaly Capital Management
NLY
$17.3B
| $23.4M | 0.09% |
548,344
-9,125
| -2% | -$417K |
|
249
CGI
GIB
$15.6B
| $23.1M | 0.09% |
683,100
-2,300
| -0.3% | -$80.9K |
|
|
CMCSK
250
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $23M | 0.09% |
429,016
-14,500
| -3% | -$776K |
|
Similar funds
Swiss National Bank's Q3 2014 Portfolio in Review
As of Q3 2014, Swiss National Bank held 2,547 positions worth $26.1B, down 3.5% from $27B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 1.3%. Swiss National Bank opened 15 new positions and exited 18, leaving the 2,547-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Energy.
- Swiss National Bank's largest Q3 2014 buy was Weatherford International plc: 735,946 shares worth $15.3M.
- Swiss National Bank added most to Allergan plc in Q3 2014, an estimated $18.3M increase.
- Swiss National Bank's biggest Q3 2014 reduction was Apple, cutting an estimated $23.7M.
- Swiss National Bank fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $23.5M.
- Swiss National Bank's ten largest holdings make up 14% of its $26.1B portfolio in Q3 2014.
- Swiss National Bank opened 15 new positions and closed 18 in Q3 2014.
- Swiss National Bank's portfolio value fell 3.5% quarter-over-quarter to $26.1B.
Based on Swiss National Bank's 13F filing for Q3 2014, filed 4 Nov 2014.